Concepedia

Daniel A.R. Heisey

DA

11

Publications

506

Citations

11

H-Index

2001

Active since

Affiliations

Massachusetts General Hospital(Current)

Center for Biologics Evaluation and Research

United States Food and Drug Administration

Harvard University

Virginia Commonwealth University

Daniel A.R. Heisey is an author at Massachusetts General Hospital specializing in medicine, flavivirus, and virology.

ORCID

Top concepts

Publications per year

2001–2021

11

Publications

11

Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination

Jungoh Ham, Carlotta Costa, Renata Sano et al. · Cancer Cell · 2016 · 130 citations · Full text

Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma

Timothy L. Lochmann, Krista M. Powell, Jungoh Ham et al. · Science Translational Medicine · 2018 · 103 citations · Full text

Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM

Kyung-A Song, Matthew J. Niederst, Timothy L. Lochmann et al. · Clinical Cancer Research · 2017 · 93 citations · Full text

The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity

Daniel A.R. Heisey, Timothy L. Lochmann, Konstantinos V. Floros et al. · Clinical Cancer Research · 2018 · 38 citations

Complete Genome Sequences of Dengue Virus Type 1 to 4 Strains Used for the Development of CBER/FDA RNA Reference Reagents and WHO International Standard Candidates for Nucleic Acid Testing

Germán Áñez, Daniel A.R. Heisey, Evgeniya Volkova et al. · Genome Announcements · 2016 · 31 citations · Full text

, , +18

Rows per page

1–5 of 11